Profile
Kenton Stewart's current job(s) include being the Senior Vice President-Market Access at Urovant Sciences Ltd. since 2020 and the Chief Commercial Officer at Sumitomo Pharma America, Inc. since 2024.
Mr. Stewart's former job was as the Senior Vice President-Health Systems at Astellas Pharma US, Inc. from 2006 to 2018.
Mr. Stewart's education history includes an MBA from Bellevue University and an undergraduate degree from Wichita State University.
Kenton Stewart active positions
| Companies | Position | Start |
|---|---|---|
| UROVANT SCIENCES LTD. | Sales & Marketing | 02/06/2020 |
Sumitomo Pharma America, Inc.
Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals for oncology, CNS, urology and rare diseases | Corporate Officer/Principal | 23/09/2024 |
Former positions of Kenton Stewart
| Companies | Position | End |
|---|---|---|
Astellas Pharma US, Inc.
Astellas Pharma US, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Corporate Officer/Principal | 01/01/2018 |
Training of Kenton Stewart
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Sumitomo Pharma America, Inc.
Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals for oncology, CNS, urology and rare diseases | Health Technology |
Bellevue University
Bellevue University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Wichita State University
Wichita State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Astellas Pharma US, Inc.
Astellas Pharma US, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Urovant Sciences Ltd.
Urovant Sciences Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and commercializes therapies for urologic conditions | Health Technology |
- Stock Market
- Insiders
- Kenton Stewart
















